141 related articles for article (PubMed ID: 29019149)
1. Leukemia Inhibitory Factor Increases Survival of Pluripotent Stem Cell-Derived Cardiomyocytes.
Blüguermann C; Romorini L; Evseenko D; Garate X; Neiman G; Sevlever GE; Scassa ME; Miriuka SG
J Cardiovasc Transl Res; 2018 Feb; 11(1):1-13. PubMed ID: 29019149
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin and CHIR99021 Coordinate Robust Cardiomyocyte Differentiation From Human Pluripotent Stem Cells Via Reducing p53-Dependent Apoptosis.
Qiu XX; Liu Y; Zhang YF; Guan YN; Jia QQ; Wang C; Liang H; Li YQ; Yang HT; Qin YW; Huang S; Zhao XX; Jing Q
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971953
[TBL] [Abstract][Full Text] [Related]
3. Functional expression and pharmaceutical efficacy of cardiac-specific ion channels in human embryonic stem cell-derived cardiomyocytes.
Kim HS; Yoon JW; Li H; Jeong GO; Park JJ; Shin SE; Jang IH; Kim JH; Park WS
Sci Rep; 2017 Oct; 7(1):13821. PubMed ID: 29062050
[TBL] [Abstract][Full Text] [Related]
4. [The influence of LIF (leukemia inhibitory factor) on the functional status of mouse line R1 embryonic stem cells].
Lobanok ES; Mezhevikina LM; Belianovich LM; Petrova RR; Vasilevich IB; Volotkovskiĭ ID; Fesenko EE
Biomed Khim; 2008; 54(5):570-6. PubMed ID: 19105399
[TBL] [Abstract][Full Text] [Related]
5. EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival.
Jara-Avaca M; Kempf H; Rückert M; Robles-Diaz D; Franke A; de la Roche J; Fischer M; Malan D; Sasse P; Solodenko W; Dräger G; Kirschning A; Martin U; Zweigerdt R
Stem Cell Reports; 2017 Feb; 8(2):305-317. PubMed ID: 28089668
[TBL] [Abstract][Full Text] [Related]
6. Effective Hypothermic Storage of Human Pluripotent Stem Cell-Derived Cardiomyocytes Compatible With Global Distribution of Cells for Clinical Applications and Toxicology Testing.
Correia C; Koshkin A; Carido M; Espinha N; Šarić T; Lima PA; Serra M; Alves PM
Stem Cells Transl Med; 2016 May; 5(5):658-69. PubMed ID: 27025693
[TBL] [Abstract][Full Text] [Related]
7. Leukemia Inhibitory Factor Enhances Endogenous Cardiomyocyte Regeneration after Myocardial Infarction.
Kanda M; Nagai T; Takahashi T; Liu ML; Kondou N; Naito AT; Akazawa H; Sashida G; Iwama A; Komuro I; Kobayashi Y
PLoS One; 2016; 11(5):e0156562. PubMed ID: 27227407
[TBL] [Abstract][Full Text] [Related]
8. Small-Molecule Induction of Canine Embryonic Stem Cells Toward Naïve Pluripotency.
Tobias IC; Brooks CR; Teichroeb JH; Villagómez DA; Hess DA; Séguin CA; Betts DH
Stem Cells Dev; 2016 Aug; 25(16):1208-22. PubMed ID: 27392793
[TBL] [Abstract][Full Text] [Related]
9. Leukemia inhibitory factor-induced Stat3 signaling suppresses fibroblast growth factor 1-induced Erk1/2 activation to inhibit the downstream differentiation in mouse embryonic stem cells.
Liu JW; Hsu YC; Kao CY; Su HL; Chiu IM
Stem Cells Dev; 2013 Apr; 22(8):1190-7. PubMed ID: 23205673
[TBL] [Abstract][Full Text] [Related]
10. STAT3-dependent mouse embryonic stem cell differentiation into cardiomyocytes: analysis of molecular signaling and therapeutic efficacy of cardiomyocyte precommitted mES transplantation in a mouse model of myocardial infarction.
Rajasingh J; Bord E; Hamada H; Lambers E; Qin G; Losordo DW; Kishore R
Circ Res; 2007 Oct; 101(9):910-8. PubMed ID: 17823373
[TBL] [Abstract][Full Text] [Related]
11. Leukemia inhibitory factor modulates cardiogenesis in embryoid bodies in opposite fashions.
Bader A; Al-Dubai H; Weitzer G
Circ Res; 2000 Apr; 86(7):787-94. PubMed ID: 10764413
[TBL] [Abstract][Full Text] [Related]
12. MLP-deficient human pluripotent stem cell derived cardiomyocytes develop hypertrophic cardiomyopathy and heart failure phenotypes due to abnormal calcium handling.
Li X; Lu WJ; Li Y; Wu F; Bai R; Ma S; Dong T; Zhang H; Lee AS; Wang Y; Lan F
Cell Death Dis; 2019 Aug; 10(8):610. PubMed ID: 31406109
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor as an anti-apoptotic mitogen for pluripotent mouse embryonic stem cells in a serum-free medium without feeder cells.
Furue M; Okamoto T; Hayashi Y; Okochi H; Fujimoto M; Myoishi Y; Abe T; Ohnuma K; Sato GH; Asashima M; Sato JD
In Vitro Cell Dev Biol Anim; 2005; 41(1-2):19-28. PubMed ID: 15926856
[TBL] [Abstract][Full Text] [Related]
14. Retinoic acid promotes metabolic maturation of human Embryonic Stem Cell-derived Cardiomyocytes.
Miao S; Zhao D; Wang X; Ni X; Fang X; Yu M; Ye L; Yang J; Wu H; Han X; Qu L; Li L; Lan F; Shen Z; Lei W; Zhao ZA; Hu S
Theranostics; 2020; 10(21):9686-9701. PubMed ID: 32863954
[TBL] [Abstract][Full Text] [Related]
15. Embryonic Stem Cells Cultured in Microfluidic Chambers Take Control of Their Fate by Producing Endogenous Signals Including LIF.
Guild J; Haque A; Gheibi P; Gao Y; Son KJ; Foster E; Dumont S; Revzin A
Stem Cells; 2016 Jun; 34(6):1501-12. PubMed ID: 26865369
[TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of different pluripotent stem cell-derived cardiac myocytes as potential testing model for cardiocytoprotection.
Pálóczi J; Szántai Á; Kobolák J; Bock I; Ruivo E; Kiss B; Gáspár R; Pipis J; Ocsovszki I; Táncos Z; Fehér A; Dinnyés A; Onódi Z; Madonna R; Ferdinandy P; Görbe A
Vascul Pharmacol; 2020; 133-134():106781. PubMed ID: 32827678
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor regulates marmoset induced pluripotent stem cell proliferation via a PI3K/Akt‑dependent Tbx‑3 activation pathway.
Ke M; He Q; Hong D; Li O; Zhu M; Ou WB; He Y; Wu Y
Int J Mol Med; 2018 Jul; 42(1):131-140. PubMed ID: 29620145
[TBL] [Abstract][Full Text] [Related]
18. Heparin Promotes Cardiac Differentiation of Human Pluripotent Stem Cells in Chemically Defined Albumin-Free Medium, Enabling Consistent Manufacture of Cardiomyocytes.
Lin Y; Linask KL; Mallon B; Johnson K; Klein M; Beers J; Xie W; Du Y; Liu C; Lai Y; Zou J; Haigney M; Yang H; Rao M; Chen G
Stem Cells Transl Med; 2017 Feb; 6(2):527-538. PubMed ID: 28191759
[TBL] [Abstract][Full Text] [Related]
19. LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.
Dahéron L; Opitz SL; Zaehres H; Lensch MW; Andrews PW; Itskovitz-Eldor J; Daley GQ
Stem Cells; 2004; 22(5):770-8. PubMed ID: 15342941
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between bone morphogenetic protein 2 and leukemia inhibitory factor through ERK 1/2 and Smad1 in protection against doxorubicin-induced injury of cardiomyocytes.
Izumi M; Masaki M; Hiramoto Y; Sugiyama S; Kuroda T; Terai K; Hori M; Kawase I; Hirota H
J Mol Cell Cardiol; 2006 Feb; 40(2):224-33. PubMed ID: 16427075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
